Atticus Wealth Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-384
Closed -$18.6K 564
2025
Q2
$18.6K Hold
384
0.01% 422
2025
Q1
$21.3K Hold
384
0.01% 316
2024
Q4
$18.5K Hold
384
0.01% 336
2024
Q3
$22.1K Sell
384
-606
-61% -$32.7K 0.01% 323
2024
Q2
$48K Hold
990
0.02% 240
2024
Q1
$48.1K Hold
990
0.02% 245
2023
Q4
$49.2K Sell
990
-500
-34% -$24.4K 0.02% 250
2023
Q3
$79.9K Hold
1,490
0.03% 195
2023
Q2
$80.3K Hold
1,490
0.03% 203
2023
Q1
$81.1K Hold
1,490
0.03% 196
2022
Q4
$72.2K Sell
1,490
-151
-9% -$6.63K 0.03% 212
2022
Q3
$82K Hold
1,641
0.04% 186
2022
Q2
$82K Buy
1,641
+1,490
+987% +$79.1K 0.03% 206
2022
Q1
$8K Buy
+151
New +$7.8K ﹤0.01% 428
2020
Q1
Sell
-42
Closed -$2K 410
2019
Q4
$2K Buy
+42
New +$1.97K ﹤0.01% 284

Other funds holding SNY

Atticus Wealth Management's SNY Position: Q3 2025 in Review

Atticus Wealth Management sold out of Sanofi (SNY) in Q3 2025, closing a stake of 384 shares — an estimated $18.6K sold.

Atticus Wealth Management first reported a position in SNY in Q4 2019 and held it in 15 quarters. The position peaked at $82K in Q3 2022. 712 funds tracked by Wall St. Rank hold SNY as of Q3 2025.

  • Atticus Wealth Management reported no remaining Sanofi position as of Q3 2025 after selling out during the quarter.
  • Atticus Wealth Management sold 384 Sanofi shares in Q3 2025, an estimated $18.6K.
  • Atticus Wealth Management first reported a position in Sanofi in Q4 2019 and held it in 15 quarters.
  • Atticus Wealth Management's Sanofi position peaked at $82K in Q3 2022.
  • 712 funds tracked by Wall St. Rank held Sanofi as of Q3 2025.

Based on Atticus Wealth Management's 13F filing for Q3 2025, filed 7 Nov 2025.